Advertisement

Document › Details
Calliditas Therapeutics AB. (7/2/20). "Press Release: Exercise of Over-allotment Option and End of the Stabilization Period".
![]() |
Region | United States (USA) |
![]() |
Organisation | Calliditas Therapeutics AB (Nasdaq Stockholm: CALTX) |
Group | Calliditas Therapeutics (Group) | |
Organisation 2 | Nasdaq Global Select Market | |
Today | Nasdaq Global Market | |
Group | Nasdaq OMX (Group) | |
![]() |
Product | investment banking |
Product 2 | Nefecon® | |
![]() |
Index term | Calliditas Therapeutics–SEVERAL: investment, 202005–202007 US IPO $81m+$6.9m with w 8.3m+707k common shares as ADSs at Nasdaq Global Market |
![]() |
Person | Aguiar-Lucander, Renée (Pharmalink AB 201708 CEO) |
Person 2 | Widell, Mikael (Pharmalink AB 201708– Head of Communications before Cord Communications + Nordic Capital) | |
Original document
accessed by [iito] on 2020-08-26
Record changed: 2020-10-21 |
Advertisement
![Picture [iito] Plain Stupid Simple 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-plain-stupid-simple.jpg)
More documents for Calliditas Therapeutics (Group)
- [1] Calliditas Therapeutics AB. (8/25/20). "Press Release: Calliditas Appoints Group General Counsel"....
- [2] Calliditas Therapeutics AB. (8/13/20). "Press Release: Calliditas Announces Agreement to Acquire Controlling Interest in Genkyotex SA"....
- [3] Calliditas Therapeutics AB. (7/24/20). "Press Release: Calliditas Reorganizes Its Management Team"....
- [4] Calliditas Therapeutics AB. (6/5/20). "Press Release: Calliditas Therapeutics Prices Its Initial Public Offering on The Nasdaq Global Select Market in the United States"....
- [5] Calliditas Therapeutics AB. (5/14/20). "Press Release: Calliditas Publicly Files Registration Statement with SEC for a Proposed Initial Public Offering in the United States"....
- [6] Calliditas Therapeutics AB. (6/10/19). "Press Release: Calliditas Therapeutics and Everest Medicines Enter into an Agreement to Develop and Commercialize Nefecon for IgA Nephropathy in Greater China and Singapore"....
- [7] Calliditas Therapeutics AB. (4/5/19). "Press Release: Elmar Schnee and Diane Parks Proposed as New Board Members of Calliditas Therapeutics". Stockholm....
- [8] Calliditas Therapeutics AB. (1/8/19). "Press Release: Calliditas Therapeutics Appoints Andrew Udell to VP Commercial, North America"....
- [9] Calliditas Therapeutics AB. (11/20/17). "Press Release: Surrogate Marker and Design of Calliditas Therapeutics’ IgA Nephropathy Phase 3 Study Agreed with the FDA". Stockholm....
- [10] Calliditas Therapeutics AB. (11/15/17). "Press Release: Pharmalink Is Renamed Calliditas Therapeutics"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top